scispace - formally typeset
M

Myron S. Cohen

Researcher at University of North Carolina at Chapel Hill

Publications -  576
Citations -  50913

Myron S. Cohen is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 103, co-authored 549 publications receiving 46021 citations. Previous affiliations of Myron S. Cohen include University of Massachusetts Medical School & Scripps Health.

Papers
More filters
Journal ArticleDOI

Free radical formation from organic hydroperoxides in isolated human polymorphonuclear neutrophils

TL;DR: It is demonstrated with EPR that organic hydroperoxides are decomposed to free radicals by both human polymorphonuclear leukocytes (PMNs) and purified myeloperoxidase and the finding of the free radical formation derived from organic hydroPeroxides by PMNs may be related to the cytotoxicity of this class of compounds.
Journal Article

Amplified transmission of HIV-1: missing link in the HIV pandemic.

TL;DR: Recognizing the increased number of subjects with unrecognized acute HIV infection in STD clinics, studies in STD Clinics in Malawi and South Africa found 563 people with undiagnosed HIV infection.
Journal ArticleDOI

Gonococcal osteomyelitis: a case report and review of the literature.

TL;DR: The single common characteristic of patients with gonococcal osteomyelitis was a substantial delay (mean 37 days) between the onset of joint symptoms and the institution of appropriate antibiotic therapy.
Journal ArticleDOI

Covid-19, Ebola, and HIV - Leveraging Lessons to Maximize Impact

TL;DR: The Covid-19 pandemic should build on lessons from the HIV and Ebola epidemics, including the importance of basing interventions on sound science and of using precautionary measures to protect against pandemics.
Journal ArticleDOI

Biological correlates of sexual transmission of HIV: Practical consequences and potential targets for public health

TL;DR: Interventions that reduce the genital shedding of HIV by reducing systemic blood viral load and/or local inflammatory processes are likely to have a beneficial impact on HIV incidence and biological data about HIV transmission must be used to inform public health policies and optimize HIV prevention strategies.